Patents Assigned to Piedmont Animal Health Inc.
  • Patent number: 11375717
    Abstract: A single-dose oral formulation of spinosad and lufenuron and methods for its use in the extended control of a flea infestation on a domestic animal such as a dog without emesis.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: July 5, 2022
    Assignee: Piedmont Animal Health Inc.
    Inventors: Douglas Hepler, Roland Johnson, Gail Dempsey, Michael Kelly
  • Patent number: 11058629
    Abstract: Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection, in particular analgesics such as buprenorphine.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: July 13, 2021
    Assignee: Piedmont Animal Health Inc.
    Inventors: Douglas I. Hepler, Gail L. Dempsey, Dorothea Erxleben
  • Patent number: 10736318
    Abstract: A single-dose oral formulation of spinosad and lufenuron and methods for its use in the extended control of a flea infestation on a domestic animal such as a dog without emesis.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: August 11, 2020
    Assignee: Piedmont Animal Health Inc.
    Inventors: Douglas Hepler, Roland Johnson, Gail Dempsey, Michael Kelly
  • Patent number: 10729709
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: August 4, 2020
    Assignee: Piedmont Animal Health Inc.
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas Hepler, Raymond Petzold